Study of SRP-4045 and SRP-4053 in Participants With Duchenne Muscular Dystrophy (DMD)
Status:
Recruiting
Trial end date:
2024-04-30
Target enrollment:
Participant gender:
Summary
The main objective of this study is to evaluate the efficacy of SRP-4045 and SRP-4053
compared to placebo in participants with DMD with out-of-frame deletion mutations amenable to
skipping exon 45 and exon 53, respectively.